drugset / Trial / NCT07241520
Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke
Phase 3
Recruiting
1096 enrolled
Shanghai Hutchison Pharmaceuticals Limited
Beijing Tiantan Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to determine the efficacy and safety of SHPL-49 intravenous infusion in acute ischemic stroke patients.
Timeline
- Start
- 2025-12-08
- Primary completion
- 2027-06-30
- Completion
- 2027-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHPL-49 | Unknown | 6 ml | Intravenous |